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Abstract
Short Video Abstract
Prediction of disease onset from patient survey and lifestyle data is quickly becom-
ing an important tool for diagnosing a disease before it progresses. In this study,
data from the National Health and Nutrition Examination Survey (NHANES)
questionnaire is used to predict the onset of type II diabetes. An ensemble model
using the output of five classification algorithms was developed to predict the on-
set on diabetes based on 16 features. The ensemble model had an AUC of 0.834
indicating high performance.
1 Introduction
Machine learning (ML) has proven itself a very useful tool in the ever expanding field of bioinfor-
matics. It has been effectively used in the early prediction of diseases such as cancer [2], and work
is being done in predicting the onset of Alzheimer’s and Parkinson’s disease [2]. These predictions
are based on data from gene sequencing and biomarkers, among other types of biological measure-
ments. Efforts have also been made to predict the onset of diseases such as type II diabetes based
on survey data. Thanks to technology that makes it much easier to collect survey data, in the future
more data may become available on a larger sample of the population. This larger volume of sur-
vey data presents a new opportunity to improve overall prediction of disease, especially in diseases
where lifestyle is highly correlated to disease onset [1].
Previous work has focused on the use of survey data to predict the onset of diabetes in a large sample
of the population using Support Vector Machines (SVM) [6], obtaining an area under the receiver
operating characteristic (ROC) curve of 0.83. The dataset used in [6] is called the National Health
and Nutrition Examination Survey (NHANES) [3]. Our goal is to use this same dataset and attempt
to improve prediction accuracy. A secondary objective is to more clearly interpret the results, and
indicate how such a model could used in the real world to improve preventative care.
This paper is organized as follows. First, we will describe the NHANES dataset to be analyzed in this
study. Next a description of the implemented classification methods will be described, along with a
description of the proposed ensemble model. Results of each proposed model will be presented that
indicate performance. Model performance will be discussed as well as some real world applications
of the proposed classification models.
2 NHANES Survey Data, Feature Section, and Label Determination
The National Health and Nutrition Examination Survey (NHANES) data is an on-going cross sec-
tional sample survey of the US population where information about participants is gathered during
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in-home interviews. In addition to the in-home surveys, participants also have the option to obtain a
physical examination in mobile examination centers [3].
2.1 Patient Exclusion and Label Assignment
As in [6], we limited our study to non-pregnant participants over 20 years of age. We focused our
efforts on three waves of the survey conducted between 1999-2004, given the consistency across
survey questions between waves from this time period.
Our problem is a binary classification, and as such we must assign labels to our samples. To do this
we used measurements from each sample. The first was the patient’s answer to the question, “Has a
doctor ever told you that you have diabetes?” If that patient answered ‘yes,’ than a ‘1’ was assigned
to the patient indicating that they had type II diabetes, and was ‘0’ otherwise. Using patients that
responded to this question produced about 900 samples. The second, and more common method
for determining the label of a patient was the value of their plasma glucose level, tested during
examination. If the patient’s glucose level was greater than 126 mg/dL, they were labeled as diabetic
and given a ‘1’. If their glucose level was less than this threshold they were assigned to the non-
diabetic group with a ‘0’. This method of labeling produced the remaining 4600 samples. With the
labels determined, we now move onto feature selection.
2.2 Feature Selection
The features were chosen to be similar to the features used in [6], since much effort was already
put in during this previous study to select good features. Additional features were examined, such
as diet, however upon further analysis most of these were excluded due to their negligible effect on
performance or a significant portion of feature data was missing (> 60% missing). Two features that
were added to the data were cholesterol and leg length, which were found to be important features
in [4]. Of the multitude of potential features, we chose to focus our attention on only 16 features.
These 16 features are described in Table 1. This made interpretation simpler and training-time
shorter. The training-time was a major concern because of the many parameters to be optimized
during cross-validation.
2.3 Cross-Validation and Test Set
After exclusion and labeling, 5515 total samples were available from the NHANES 1999 to 2004
dataset. Before model training, a 20% test set was removed from the entire dataset. This left 4412
samples for training and 1103 for testing.
For hyperparameter tuning 10-fold cross validation was used, with grid-search. To obtain testing
accuracy error, bootstrapping was utilized.
3 Methods
All modeling was done using scikit-learn, a python-based toolkit for simple and efficient machine
learning, data mining and data analysis [5].
3.1 Individual Models
Five simple models were chosen that presented fairly high discriminative power on their own: Lo-
gistic Regression, K-Nearest Neighbors (KNN), Random Forests, Gradient Boosting, and Support
Vector Machine (SVM). Other models such as Naive Bayes were tried, but did not produce accurate
results compared to the five previous models.
Each model had a few hyperparameters associated with it. The five models in total contained a
total of 10 hyperparameters. Using grid search would be intractable to tune all the hyperparameters
simultaneously, since to test even just 10 values for each would produce 1010 evaluations. Instead,
each model was tuned separately, with the result being shorter tuning times that were possible on a
laptop computer.
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Table 1: Feature Description Table with Feature Importance Ranked Based on Random Forest Clas-
sifier
Feature Name DESCRIPTION NHANES Code Feature Importance
AGE Age at time of screening RIDAGEYR 0.169
WAIST Waist circumference (cm) BMXWAIST 0.107
REL Blood relatives have diabetes? MCQ250A 0.087
HEIGHT Height (cm) BMXHT 0.086
CHOL Total cholesterol (mg/dL) LBXTC 0.085
LEG Upper Leg Length (cm) BMXLEG 0.080
WEIGHT Weight (kg) BMXWT 0.071
BMI Body mass index (kg/m2) BMXBMI 0.067
RACE Race/ethnicity RIDRETH1 0.050
HBP High blood pressure? BPQ020 0.046
INCOME Annual household income (dollars) INDHHINC 0.039
ALC Amount of alcohol in past year? ALQ120Q 0.038
SMOKE Age started smoking cigarettes regularly SMD030 0.036
EDU Education level DMDEDUC2 0.017
EXER Daily physical activity level PAQ180 0.012
GEND Gender RIAGENDR 0.011
Trained Model 1 
Logistic Regression 
Trained Model 2 
KNN 
Trained Model 3 
Random Forests 
Trained Model 4 
Gradient Boosting 
Trained Model 5 
Support Vector Machine 
Ensemble Model 
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Figure 1: Schematic of Ensemble Model Classifier. Each trained model outputs a probability p. The
ensemble model takes each of these probabilities and calculates the unweighted average probability,
p¯. Finally, the decision boundary T is selected based on tuning from recall results. Initially T=0.5,
but by adjusting T, higher diabetes prediction rates can be obtained at the expense of labeling more
healthy patients as diabetics.
3.2 Ensemble Model
After training, the five previously described models were set to output probabilities p. These prob-
abilities were then fed into the ensemble model (see Figure 1), which took an unweighted average
of the inputs to obtain p¯. Initially, as is typical, T was set to 0.5. This however lead to a very poor
recall rate on the diabetic patients. Because of this observation of very high type II error (i.e. low re-
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Figure 2: Receiver Operating Characteristic (ROC) curves are plotted for each individual model and
the ensemble model. The dotted line represents random-guessing. The performance metrics can be
found in Table 2.
call), and considering that it is of greater importance to identify a diabetic than misidentify a healthy
patient, the decision boundary T was adjusted to obtain a more desirable recall rate.
4 Results
4.1 Overall Discriminative Power of All Models
The overall discriminative power of the model is shown by the Receiver Operating Characteristic
(ROC) curves in Figure 2. From the figure it can be seen that the Gradient Boosting Classifier
performs best with an AUC of 0.84. Random forests also performs exceptionally well. The other
three classifiers were noticeably worse at classification, with the worst performance being the KNN.
The AUCs of each individual model, as well as other metrics, can be found in Table 2.
Unfortunately, the ensemble model failed to significantly improve performance. In fact it was less
accurate than the Gradient Boost Classifier as measured by AUC. However the difference between
the two was very small, as seen in the performance metrics in Table 2.
4.2 Recall and the Decision Boundary T
The recall rate for the diabetics is defined as the number of diabetics identified, over the total number
of diabetics in the sample. The recall rate is a function of the decision boundary T, and is plotted
for the best performing classifier, Gradient Boosting, in Figure 3. Recall was also plotted for all
the models for each class in Figure 4. At the default decision boundary of T=0.5, the recall rate
for diabetics was only 0.35, meaning that only 35% of the time we classify a diabetic patient that
in-fact has diabetics. Since our objective is to maximize our ability to identify diabetics, we decided
to shift our decision boundary to a point which would allow us to identify diabetics at least 75% of
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Table 2: Performance Metrics for the Five Models, and the Ensemble Model
Model AUC F1 Score Recall Precision
K-Nearest Neighbors 0.793 0.73 0.82 0.67
Logistic Regression 0.797 0.79 0.81 0.78
Support Vector 0.812 0.79 0.82 0.78
Random Forests 0.817 0.79 0.82 0.79
Gradient Boosting 0.840 0.81 0.82 0.80
Ensemble 0.834 0.78 0.82 0.78
the time. To achieve this, we shifted out decision boundary rightward to T=0.78, where the recall
rate for diabetics was 0.75, and coincidentally, the recall rate for non-diabetics was also 0.75. This
means that by shifting our decision boundary, we were able to identify many more diabetics, only
having to sacrifice a small decrease in recall rate of 18% for the non-diabetics.
Figure 3: Recall vs. Decision Boundary T curves for diabetics and non-diabetics for the top per-
forming classifier, Gradient Boosting. At the default classification of T=0.5 (middle dotted line),
the recall rate is 0.93 for non-diabetics and 0.35 for diabetics. For T=0.78 (right dotted line) the
recall rate for non-diabetics is 0.75 and the recall rate for diabetics is 0.75, representing a large im-
provement in identifying the diabetics patients with only a small sacrifice in recall rate (18%) for the
non-diabetics.
4.3 Testing Error
In order to obtain the error on the test accuracy results, bootstrapping was performed for training
on the best performing model, the Gradient Boosting Classifier. This produced Nboot classifiers, all
having slightly different discriminative abilities. To show the error in classification, ROC curves with
continuous upper and lower error bars are shown in Figure 5. This figure plots three ROC curves, the
middle one is the average ROC curve for all the Nboot trained models. The upper and lower curves
are the 2.5% and 97.5% empirical quantiles of the bootstrap sample (i.e. 95% confidence intervals).
To obtain this distribution, Nboot = 1000 models were trained. Mean AUC from bootstrapping was
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Figure 4: Recall vs. Decision Boundary curves for diabetic and non-diabetics by model. The Gra-
dient Boosting Classifier had the highest performance, with the KNN classifier having the poorest
performance. The other three models had similar performance. Metrics are shown in Table 2.
0.83, with upper and lower confidence intervals of 0.82 and 0.84. This indicates that the training is
not highly sensitive to the training data.
5 Discussion and Applications
5.1 Model Performance
Five models were used to classify diabetics and non-diabetics based on survey data collected from
NHANES. These five models were given equal weighting in an ensemble model that used the prob-
abilistic output of each model. From the ROC curves of all the models (seen in Figure 2) it was
found that the best performing model (the highest AUC, seen in Table 2) was the Gradient Boosting
Classifier, which actually beat out the ensemble method.
At first glance, it is surprising that the lone Gradient Boosting Classifier performed best, as it was
thought that the wisdom of each model would combine into the best classifier through an ensemble
method. This would have been consistent with the theory of the ‘wisdom of crowds.’ The poorer
performance of the ensemble method could be due to a few factors. The first is that there was inade-
quate hyperparameter tuning. To prevent the need to tune 10 hyperparameters simultaneously, which
would have taken an exorbitant amount of time, we instead chose to tune each model separately. In
doing this we prevented the ensemble model from really using the best features of each model, as
we did not allow for the tuning of hyperparameters based on ensemble performance. An additional
hyperparameter that should have been optimized was the weighting of each model. Our ensemble
model weighted each model equally, which may have given too much weight to poorer performing
models such as the KNN Classifier (the AUC for this model was much lower than the AUC of the
other 4 models).
In the future, if computational time were not an issue, simultaneous tuning of hyperparameters
would be carried out. Additional performance enhancement could also be achieve by implement-
ing a ‘stacked model,’ which is essentially a two-layered model that would use the output of each
individual model as a feature to train a lower dimensional model.
One of our preprocessing steps was to impute values for missing data. This is particularly impor-
tant because >25% of cells are missing values. For numerical features (e.g. BMI and height) we
calculated the mean from the training data and assigned it to missing fields in both training and test
sets. For categorical variables (e.g. income bracket and alcohol use) we assigned missing values the
most common label from the training set. Further performance enhancement could also be obtained
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Figure 5: ROC curve for the Gradient Boosting Classifier. Also plotted are the 2-standard deviation
spread representing the testing performance for models trained on Nboot bootstrapped samples. The
very small difference between the average (middle curve) and the top and bottom curves show that
the model performance is not sensitive to the training data. The dotted line is the performance
associated with random guessing.
by imputing missing data by building a model from the available data to predict missing values for
a given feature and through matrix factorization.
The top AUCs from the models presented in this paper were consistent with the work of [6], who
achieved and AUC of 0.83 for a well-tuned support vector machine. Our consistency with this pre-
vious study indicates that the 0.83 AUC may be a hard upper limit on the discriminative power of
models trained on the NHANES data for the purpose of the prediction of diabetes using simple clas-
sification techniques such as those discussed in the present work and in [6]. However, considering
only marginal effort was made to impute data in either works, clever data imputation may present
the best path for increasing performance.
5.2 Applications
When creating classification models for disease detection it is always important to keep the end use
in mind. The classification model presented here is used for the purpose of early detection of type II
diabetes based on easily obtainable survey data. The features are responses to questions and simple
examination measurements shown in Table 1.
A decision boundary of T=0.78 was chosen that produced a recall rate of 75% for diabetics, meaning
that 75 out of 100 diabetics were correctly identified. This was considered an acceptable outcome
from a diagnostic standpoint. However, the caveat is that to ensure a 75% recall rate in diabetics,
many non-diabetics will be identified as diabetics. To give specific numbers, with a recall rate of
75% for non-diabetics, we can eliminate 5515 * 0.81*0.75 = 3350 patients from the total population
of 5515 (0.81 is the proportion of non-diabetics in the entire training set). This would leave 2165
patients left, which would be the number of patients that would need to be notified they were diabetic
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in order to ensure 75% of the actual diabetics are notified. This may provide a significant decrease
in over healthcare cost, by increasing preventative care for the notified patients. With this possibility
in mind, a public health expert can decide whether this classification scheme is cost-effective.
6 Conclusions
Five separate models were used to classify diabetics vs. non-diabetics. The output of these models
was used to create an ensemble model, which had 0.834 AUC. The best performing model was not
the ensemble model, but rather the Gradient Boosting Classifier, which obtained 0.84 AUC. This
AUC is consistent with previous findings and indicates that in using survey data one can expect
reasonable classification performance.
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